含替吉奥联合化疗方案治疗进展期胃癌研究的进展

被引：38

作者：

李小平

郑磊贞

机构：

[1] 上海交通大学医学院新华医院肿瘤科

来源：

临床肿瘤学杂志 | 2009年 / 14卷 / 11期

关键词：

替吉奥胶囊; 晚期胃癌; 化学治疗;

D O I：

暂无

中图分类号：

R735.2 [胃肿瘤];

学科分类号：

100112 [医学生物化学与分子生物学];

摘要：

替吉奥胶囊(S-1)是替加氟及优福定的升级换代产品,使用替吉奥联合化疗方案治疗晚期胃癌在不同的临床研究中取得了初步肯定的治疗效果,毒副作用小,疗效确切,给药方便。本文就含替吉奥联合化疗方案治疗进展期胃癌的研究进展作一综述。

引用

页码：1048 / 1051

页数：4

共 8 条

[1]

Dose-finding study of docetaxel, oxaliplatin, and S-1 for patients with advanced gastric cancer [J].

Zang, Dae Young ;

Yang, Dae Hyun ;

Kim, Min-Jeong ;

Jang, Kyung Mi ;

Hwang, Se Won ;

Yoo, Kyo-Sang ;

Han, Taeho ;

Kim, Ho Young ;

Kim, Hyo Jung ;

Kwon, Jung Hye ;

Song, Hun Ho ;

Park, Sarah ;

Jung, Joo Young ;

Kim, Hyeong Su ;

Kim, Jung Han .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (05) :877-883

[2]

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial [J].

Koizumi, Wasaburo ;

Narahara, Hiroyuki ;

Hara, Takuo ;

Takagane, Akinori ;

Akiya, Toshikazu ;

Takagi, Masakazu ;

Miyashita, Kosei ;

Nishizaki, Takashi ;

Kobayashi, Osamu ;

Takiyama, Wataru ;

Toh, Yasushi ;

Nagaie, Takashi ;

Takagi, Seiichi ;

Yamamura, Yoshitaka ;

Yanaoka, Kimihiko ;

Orita, Hiroyuki ;

Takeuchi, Masahiro .

LANCET ONCOLOGY, 2008, 9 (03) :215-221

[3]

Chemotherapy for advanced gastric cancer: ongoing phase III study of S-1 alone versus S-1 and docetaxel combination (JACCRO GC03 study) [J].

Fujii, Masashi .

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2008, 13 (03) :201-205

[4]

Effects of combined administration of DPD-inhibitory oral fluoropyrimidine, S-1, plus paclitaxel on gene expressions of fluoropyrimidine metabolism-related enzymes in human gastric xenografts [J].

Sakurai, Yoichi ;

Yoshida, Ikuo ;

Kamoshida, Shingo ;

Inaba, Kazuki ;

Isogaki, Jun ;

Komori, Yoshiyuki ;

Uyama, Ichiro ;

Tsutsumi, Yutaka .

ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (08) :2301-2309

[5]

Phase I/II trial of combination therapy with S-1 and weekly paclitaxel in patients with unresectable or recurrent gastric cancer [J].

Inada, Seisuke ;

Tomidokoro, Takashi ;

Fukunari, Hiroyuki ;

Sato, Tomomi ;

Hatano, Toru ;

Nishimura, Atsushi ;

Kawauchi, Yasuyuki ;

Nikkuni, Keiya ;

Shimizu, Takeaki ;

Sato, Toshiteru ;

Yanagi, Masahiko ;

Takahashi, Satoru ;

Yoshida, Hideki ;

Sugita, Minoru ;

Hayashi, Tetsuji .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (02) :267-273

[6]

A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer [J].

Nakajo, Akihiro ;

Hokita, Shuichi ;

Ishigami, Sumiya ;

Miyazono, Futoshi ;

Etoh, Tadaaki ;

Hamanoue, Masahiro ;

Maenohara, Shigeho ;

Iwashita, Toshimitsu ;

Komatsu, Hideaki ;

Satoh, Kiyoharu ;

Aridome, Kuniaki ;

Morita, Satoshi ;

Natsugoe, Shoji ;

Takiuchi, Hiroya ;

Nakano, Shyuji ;

Maehara, Yoshihiko ;

Sakamoto, Junichi ;

Aikou, Takashi ;

Taxol, Kyushu .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (06) :1103-1109

[7]

Paclitaxel versus docetaxel for advanced gastric cancer: a randomized phase II trial in combination with infusional 5-fluorouracil [J].

Park, Se Hoon ;

Lee, Woon Kee ;

Chung, Min ;

Lee, Yuna ;

Han, Sang Hoon ;

Bang, Soo-Mee ;

Cho, Eun Kyung ;

Shin, Dong Bok ;

Lee, Jae Hoon .

ANTI-CANCER DRUGS, 2006, 17 (02) :225-229

[8]

Retrospective analysis of 45 consecutive patients with advanced gastric cancer treated with neoadjuvant chemotherapy using an S-1/CDDP combination [J].

Satoh S. ;

Hasegawa S. ;

Ozaki N. ;

Okabe H. ;

Watanabe G. ;

Nagayama S. ;

Fukushima M. ;

Takabayashi A. ;

Sakai Y. .

Gastric Cancer, 2006, 9 (2) :129-135

← 1 →